FDA Inspection 1338152 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on Sep 3, 2026 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 3, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Birmingham, AL (United States)